(Q33877385)
Statements
1 reference
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial (English)
1 reference
C Le Tourneau
X Paoletti
D Gentien
T Rio Frio
J Romejon
O Mariani
V Bernard
P Huppe
G Pierron
F Mulot
C Callens
J Wong
C Mauborgne
E Rouleau
C Reyes
E Henry
Q Leroy
P La Rosa
L Escalup
E Mitry
J-P Delord
M Campone
A Goncalves
N Isambert
C Gavoille
M Kamal
24 April 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference